Answers are grounded in this paper and cite their sources.
Methylglyoxal generated by cSMCs induced cECs dysfunction, inflammation, hypoxia and exaggerated ischaemia-reperfusion injury in diabetic rats. Lowering methylglyoxal produced by cSMCs may be a viable therapeutic strategy to preserve cECs function and blunt deleterious downstream consequences in T1D.
No takes yet. Share an insight, caveat, or question.
Alomar et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: